Clinical trial shows five-year outcomes of CAR T-cell therapy for non-Hodgkin lymphomas
A significant number of non-Hodgkin lymphoma (NHL) patients in a Penn Medicine-initiated clinical trial continue to be in remission five
Read more
A significant number of non-Hodgkin lymphoma (NHL) patients in a Penn Medicine-initiated clinical trial continue to be in remission five
Read moreA study has found that new drug carbetocin can prevent excessive bleeding after childbirth thus saving the lives of thousands
Read more